文献速递甲状腺疾病

儿童甲状腺细胞学恶性风险的年龄分层:基于验前概率重新定义ROM

Age-specific risk of malignancy in pediatric thyroid cytology: Reframing ROM based on pre-test probability.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究分析2728例0-25岁患者的甲状腺细针穿刺(FNA),按2023 Bethesda系统分类并分四个年龄组,计算下限和手术上限恶性风险(ROM)、似然比(LR)及验后概率。结果显示恶性患病率随年龄下降(手术病例中0-8岁84.2% vs 19-25岁64.6%),验证偏倚显著(下限24.6% vs 手术病例67.7%),年龄分层LR框架可量化偏倚并提供个体化风险估计。

要点

  • 儿童甲状腺结节恶性率随年龄增长而下降,手术病例中0-8岁达84.2%。
  • 验证偏倚显著:下限ROM为24.6%,手术病例上限ROM达67.7%。
  • 年龄分层似然比可个体化评估验后恶性概率,指导手术与随访决策。

核心结论

  • 年龄显著影响儿童甲状腺细胞学的验前和验后恶性概率。
  • 年龄分层似然比框架有助于量化验证偏倚并提供个体化风险估计。

研究设计与样本

  • 多中心回顾性分析2728例0-25岁患者甲状腺细针穿刺(FNA),2000-2023年。
  • 按2023 Bethesda系统分类或再分类,分为0-8、9-14、15-18、19-25岁四个年龄组。
  • 计算下限ROM(假设未手术FNA为良性)和手术上限ROM(991例有组织学)。
  • 使用年龄别验前概率和Bethesda类别似然比,通过贝叶斯定理计算验后恶性概率。

主要发现

  • 手术病例中恶性患病率随年龄下降:0-8岁84.2%,19-25岁64.6%。
  • 验证偏倚显著:下限假设恶性患病率24.6%(671/2728),手术病例中67.7%(671/991)。
  • 各Bethesda类别上限ROM为下限ROM的2-10倍。
  • 良性细胞学似然比低(0.07-0.15),验后恶性概率降至0-25%。
  • 不确定类别存在年龄相关变异:9岁滤泡性肿瘤验后风险约71%,24岁约49%。

关键数值与推荐

  • 下限ROM假设未手术FNA为良性,手术上限ROM基于991例有组织学病例。
  • 良性细胞学似然比0.07-0.15,验后恶性概率0-25%。
  • 滤泡性肿瘤在9岁验后风险约71%,24岁约49%。

临床怎么用

  • 儿童甲状腺细胞学风险评估应结合年龄分层似然比。
  • 年龄分层框架可辅助手术、分子检测和随访的个体化决策。

局限性

  • 验证偏倚影响ROM估计,下限和上限分别基于不同假设。
  • AUS亚型未能一致区分ROM。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pediatric thyroid nodules are uncommon but have a higher malignancy rate than adult nodules. Existing Bethesda risk-of-malignancy (ROM) estimates are not age-stratified and are affected by verification bias. We aimed to generate age-specific ROM, likelihood ratios (LRs), and post-test malignancy probabilities for pediatric and young adult thyroid cytology. METHODS: We analysed 2728 thyroid fine-needle aspirations (FNAs) from patients aged 0-25 years across multiple tertiary centers (2000-2023). All cases were classified or reclassified using the 2023 Bethesda System and grouped into four age bands (0-8, 9-14, 15-18, and 19-25 years). We calculated lower-bound ROM (ROM overall; assuming nonoperated FNAs were benign) and surgery-only upper-bound ROM (ROM surgery; 991 of 2728 cases with histology). Age-specific pretest probabilities and Bethesda-category LRs were used to compute post-test malignancy probabilities with Bayes' theorem. RESULTS: Among operated nodules, malignancy prevalence decreased with age (84.2% at 0-8 years to 64.6% at 19-25 years). Verification bias was substantial: malignancy prevalence was 24.6% (671/2728) under the lower-bound assumption but 67.7% (671/991) among surgical cases. Upper-bound ROM values were 2-10 times higher than lower-bound values across categories. Benign cytology showed low LRs (0.07-0.15), reducing post-test malignancy probability to 0-25%. Indeterminate categories showed age-related variation; for example, a follicular neoplasm diagnosis carried a ∼71% post-test risk in a 9-year-old versus ∼49% in a 24-year-old. AUS subtyping (nuclear vs other atypia) did not consistently separate ROM. CONCLUSION: Age substantially modifies both pretest and post-test malignancy probabilities in pediatric thyroid cytology. An age-stratified LR framework helps quantify verification bias and provides individualized risk estimates to guide decisions about surgery, molecular testing, and follow-up.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Canberk S, Baloch ZW, Isaza A, et al. Age-specific risk of malignancy in pediatric thyroid cytology: Reframing ROM based on pre-test probability. J Clin Endocrinol Metab. 2026. PMID: 41739856. doi:10.1210/clinem/dgag073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。